Pharmacogenetics Testing in Psychiatry and Depression Market Grows as Personalized Mental Health Care Advances
"Global Demand Outlook for Executive Summary Pharmacogenetics Testing in Psychiatry/Depression Market Size and Share CAGR Value The global pharmacogenetics testing in psychiatry/depression market size was valued at USD 1.34 billion in 2024 and is expected to reach USD 2.97 billion by 2032, at a CAGR of 10.4% during the forecast period...
0 التعليقات 0 المشاركات 78 مشاهدة 0 معاينة
Abistem https://abistem.com